3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
Three-dimensional MR Elastography for Assessing Cirrhosis and Portal Hypertension (CHESS2206): A Prospective Multicenter Study
Shengjing Hospital
150 participants
Aug 16, 2022
OBSERVATIONAL
Conditions
Summary
How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis or advanced chronic liver disease. We plan to investigate the ability of three demensional-magnetic resonance elastography (3D-MRE) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis or advanced chronic liver disease.
Eligibility
Interventions
All imaging studies were performed by using a 3.0-T MRI system ( GE Healthcare) with a phasedarray body coil.
HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05475015